Ligand Pharmaceuticals Inc
F:LGDN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Ligand Pharmaceuticals Inc
F:LGDN
|
US |
|
E
|
Ensign Group Inc
F:EGB
|
US |
|
B
|
Bureau Veritas SA
F:4BV
|
FR |
|
B
|
Barclays PLC
OTC:BCLYF
|
UK |
|
Banco Santander SA
OTC:BCDRF
|
ES |
|
C
|
China Petroleum & Chemical Corp
XMUN:CHU
|
CN |
|
Bandai Namco Holdings Inc
TSE:7832
|
JP |
|
IMCD NV
F:X6D
|
NL |
|
E
|
Ems Chemie Holding AG
XMUN:EMC1
|
CH |
|
Unity Software Inc
BMV:U
|
US |
|
CNO Financial Group Inc
NYSE:CNO
|
US |
|
K
|
Khanh Hoa Power JSC
VN:KHP
|
VN |
|
Daiwa House Industry Co Ltd
F:DWH
|
JP |
|
N
|
NEO Battery Materials Ltd
OTC:NBMFF
|
CA |
|
Security Federal Corp
OTC:SFDL
|
US |
|
WSFS Financial Corp
NASDAQ:WSFS
|
US |
|
Morguard Corp
TSX:MRC
|
CA |
|
One 97 Communications Ltd
BSE:543396
|
IN |
|
M
|
Maximus Inc
F:MMY
|
US |
|
M
|
Modine Manufacturing Co
F:MMF
|
US |
|
E
|
Exelon Corp
XHAM:PEO
|
US |
|
Eagle Pharmaceuticals Inc
OTC:EGRX
|
US |
|
L
|
LPN Development PCL
SET:LPN
|
TH |
|
E
|
Erste Group Bank AG
XBSE:EBS
|
AT |
Bankruptcy Probability
Ligand Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Ligand Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Ligand Pharmaceuticals Inc
NASDAQ:LGND
|
6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
622.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
355B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
338.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
224.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
184.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
317B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
160.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Ligand Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Ligand Pharmaceuticals Inc has total debt of 1.1B USD. This includes both short-term (0 USD) and long-term (1.1B USD) debt.
You can find a full breakdown on its Balance Sheet.